Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Repeat Dose Safety Study for Compound to Treat Asthma

This study has been completed.
Sponsor:
Information provided by:
Accenture
ClinicalTrials.gov Identifier:
NCT01202214
First received: September 13, 2010
Last updated: January 28, 2011
Last verified: January 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given